Skip to main content
. 2020 Jun 21;21(12):4407. doi: 10.3390/ijms21124407

Table 3.

Pharmacokinetics for Whole Brain Uptake.

Exosome Ki Vi n * r2 * p< * Pattern %Par
J774A.1NC 0.083 ± 0.017 1.72 12 0.710 0.001 Linear 92 ± 0.6
NIH-3T3NC 0.103 ± 0.040 1.11 10 0.455 0.05 Plateau 58 ± 3.7
Primary T CellNC 0.547 ± 0.116 3.19 10 0.736 0.005 Plateau 85 ± 2.9
HaCaTNC Flat 58 ± 8.1
SCC-90C 0.123 ± 0.015 2.40 12 0.866 0.001 Linear 77 ± 2.0
PCI-30C 0.057 ± 0.011 4.11 13 0.721 0.001 Linear 71 ± 2.9
SCCVIIC 0.162 ± 0.015 1.07 18 0.884 0.001 Plateau 93 ± 3.0
MDA-MB-231C 0.098 ± 0.034 3.66 10 0.514 0.05 Plateau 64 ± 4.5
MEL526C 0.091 ± 0.035 1.7 7 0.579 0.05 Plateau 72 ± 3.9
KasumiC 0.044 ± 0.013 3.3 11 0.568 0.01 Linear 79 ± 4.6

Ki in units of μL/g-min reported with SE; Vi in units of μL/g; %Par is the percent in parenchyma (capillary depletion), reported as mean with its standard error for an n = 3; * for linear portion of curve only. HaCaT did not show a statistically significant correlation between brain/serum ratios and time and its mean brain/serum ratio was 2.9 +/− 0.31 (n = 10). Superscript NC = noncancerous; superscript C = cancerous.